Literature DB >> 11339279

Peptide repertoire of human cerebrospinal fluid: novel proteolytic fragments of neuroendocrine proteins.

M Stark1, O Danielsson, W J Griffiths, H Jörnvall, J Johansson.   

Abstract

Polypeptides in human cerebrospinal fluid (CSF), isolated by phase separation in chloroform-methanol-water and reversed-phase HPLC, were characterised by sequence analysis and mass spectrometry. This identified the presence of peptide fragments of testican, neuroendocrine specific protein VGF, neuroendocrine protein 7B2, chromogranin B/secretogranin I, chromogranin A, osteopontin, IGF-II E-peptide and proenkephalin. The majority of these fragments were generated by proteolysis at dibasic sites, suggesting that they are derived by activities related to prohormone convertase(s). Several of the fragments have previously not been detected, and their functions in CSF or elsewhere are unknown. A characteristic feature of all these fragments is a very high content of acidic residues, in particular glutamic acid. In addition to the fragments of neuroendocrine proteins, endothelin-binding receptor-like protein 2, ribonuclease 1, IGF-binding protein 6, albumin, alpha1-acid glycoprotein 1, prostaglandin-H2 D-isomerase, apolipoprotein A1, transthyretin, beta2-microglobulin, ubiquitin, fibrinopeptide A, and C4A anaphylatoxin were found.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11339279     DOI: 10.1016/s0378-4347(00)00628-9

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  12 in total

1.  Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases.

Authors:  Xin Wei; Lingjun Li
Journal:  Int J Clin Exp Pathol       Date:  2008-06-20

2.  G protein-coupled receptor 37L1 regulates renal sodium transport and blood pressure.

Authors:  Xiaoxu Zheng; Laureano D Asico; Xiaobo Ma; Prasad R Konkalmatt
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-19

3.  Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid.

Authors:  Karl T Hansson; Tobias Skillbäck; Elin Pernevik; Jessica Holmén-Larsson; Gunnar Brinkmalm; Kaj Blennow; Henrik Zetterberg; Johan Gobom
Journal:  J Vis Exp       Date:  2017-12-04       Impact factor: 1.355

Review 4.  Peptidomic Approaches and Observations in Neurodegenerative Diseases.

Authors:  Besnik Muqaku; Patrick Oeckl
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 5.  Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor.

Authors:  Andrea Levi; Gian-Luca Ferri; Elizabeth Watson; Roberta Possenti; Stephen R J Salton
Journal:  Cell Mol Neurobiol       Date:  2004-08       Impact factor: 5.046

6.  Discovering new bioactive neuropeptides in the striatum secretome using in vivo microdialysis and versatile proteomics.

Authors:  Benoît Bernay; Marie-Claude Gaillard; Vilém Guryca; Anouk Emadali; Lauriane Kuhn; Anne Bertrand; Isabelle Detraz; Carole Carcenac; Marc Savasta; Emmanuel Brouillet; Jérôme Garin; Jean-Marc Elalouf
Journal:  Mol Cell Proteomics       Date:  2009-01-21       Impact factor: 5.911

7.  The role of the vgf gene and VGF-derived peptides in nutrition and metabolism.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Andrea Levi; Flaminia Pavone; Anna Moles
Journal:  Genes Nutr       Date:  2007-10-18       Impact factor: 5.523

8.  Plasma proenkephalin A 119-159 on intensive care unit admission is a predictor of organ failure and 30-day mortality.

Authors:  Attila Frigyesi; Lisa Boström; Maria Lengquist; Patrik Johnsson; Oscar H M Lundberg; Martin Spångfors; Martin Annborn; Tobias Cronberg; Niklas Nielsen; Helena Levin; Hans Friberg
Journal:  Intensive Care Med Exp       Date:  2021-07-19

9.  Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.

Authors:  Mikko Hölttä; Henrik Zetterberg; Ekaterina Mirgorodskaya; Niklas Mattsson; Kaj Blennow; Johan Gobom
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

10.  A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans.

Authors:  Mikko Hölttä; Robert A Dean; Eric Siemers; Kwasi G Mawuenyega; Wendy Sigurdson; Patrick C May; David M Holtzman; Erik Portelius; Henrik Zetterberg; Randall J Bateman; Kaj Blennow; Johan Gobom
Journal:  Alzheimers Res Ther       Date:  2016-03-07       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.